News ResMed Inc. Australian S.E.

Equities

Market Closed - Australian S.E. Other stock markets 02:10:05 2024-04-29 am EDT			5-day change	1st Jan Change
32.58 ^AUD	+3.43%		+15.57%	+28.07%

Apr. 26	Sector Update: Health Care Stocks Edge Higher Late Afternoon	MT
Apr. 26	Top Midday Gainers	MT

Morgans rates RMD as Add	10:31pm	AQ
Sector Update: Health Care Stocks Edge Higher Late Afternoon	Apr. 26	MT
Top Midday Gainers	Apr. 26	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	Apr. 26	MT
In-Line Inflation Data, Tech Earnings Lift US Equity Indexes	Apr. 26	MT
Sector Update: Health Care	Apr. 26	MT
KeyBanc Adjusts Price Target on ResMed to $238 From $227	Apr. 26	MT
ResMed's Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Up Over 17%	Apr. 26	MT
Jefferies Adjusts Price Target on ResMed to $180 From $164	Apr. 26	MT
Oppenheimer Adjusts ResMed Price Target to $200 From $205, Maintains Outperform Rating	Apr. 26	MT
JPMorgan Adjusts Price Target on ResMed to $225 From $198	Apr. 26	MT
Mizuho Adjusts Price Target on ResMed to $220 From $215	Apr. 26	MT
Needham Adjusts Price Target on ResMed to $236 From $224	Apr. 26	MT
Morgan Stanley Adjusts Price Target on ResMed to $219 From $207	Apr. 26	MT
RBC Adjusts Price Target on ResMed to $200 From $187	Apr. 26	MT
ResMed Declares Quarterly Dividend as Fiscal Q3 Profit Jumps 29%; Shares Up 7%	Apr. 25	MT
ResMed tops quarterly profit estimates on strong demand for sleep apnea devices	Apr. 25	RE
ResMed : Q3 2024 ResMed Earnings Results Webcast Corporate 1-Pager	Apr. 25	PU
ResMed : Q3 2024 ResMed Earnings Results Webcast Presentation	Apr. 25	PU
ResMed Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Rise After Hours	Apr. 25	MT

No results for this search

ResMed, Inc. continues to make headway in the sleep market

December 11, 2023 at 05:55 am EST